Artificial Nanoscale Erythrocytes from Clinically Relevant Compounds for Enhancing Cancer Immunotherapy
Crossref DOI link: https://doi.org/10.1007/s40820-020-00428-y
Published Online: 2020-04-13
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ou, Wenquan
Nam, Kang Sik
Park, Dae Hoon
Hwang, Jungho
Ku, Sae Kwang
Yong, Chul Soon
Kim, Jong Oh
Byeon, Jeong Hoon
Text and Data Mining valid from 2020-04-13
Version of Record valid from 2020-04-13
Article History
Received: 17 January 2020
Accepted: 12 March 2020
First Online: 13 April 2020